1 Forgotten Weed Stock Could Make a Mighty Comeback in 2020

Investors dumped the Canopy Growth stock in 2019 because of its very disappointing performance. New catalysts, however, should help the most popular cannabis producer to make a mighty rebound in 2020.

| More on:

The marijuana boom was supposed to happen last year. Many were expecting Canopy Growth (TSX:WEED)(NYSE:CGC) to lead the advance. All eyes, including that of Constellation Brands, were on its founder and erstwhile CEO Bruce Linton.

The American alcoholic beverage giant has a $4 billion investment, or 38% stake in the world’s largest publicly traded cannabis company by market value. With mounting losses after the Q2 2019, the Constellation Brands-controlled board has had enough of Linton’s free-spending ways.

Falling out

The board of directors felt a leadership change was in order, and Linton had to go. In spite of his termination in early July 2019, Linton bought WEED shares, saying the change signals the right time to buy.

From $53.52 on July 3, 2019, the price fell by nearly 65% to $18.78 in mid-November. The value of the entire cannabis industry also collapsed.

Canopy Growth was without a permanent CEO throughout the period. Also, it was dealing with supply issues and was having problems selling cannabis products abroad. More seriously, the company was losing money at a rapid pace.

Right man for the job

The good news came on December 9, 2019. As soon as the company announced the hiring of a new CEO, the stock rose to $28.17. Constellation chose a senior executive to take over the helm. It now appears that Canopy Growth is taking the right track in 2020.

Constellations Brand’s CFO David Klein is the chosen one. He’s leaving his post to take the helm at Canopy Growth effective January 14, 2020. Based on the company’s press release, Klein is the right man for the job.

He brings extensive experience from the consumer-packaged-goods (CPG) and the beverage alcohol industry. He has experienced too operating in highly regulated markets in Canada, Europe, Mexico, and the U.S.

With Klein’s strong financial orientation, expect Canopy Growth to depart from Linton’s boldness and do more belt-tightening. Some analysts, however, are uneasy about the appointment. Klein is facing an acid test given that he has zero experience in the cannabis arena.

Right product mix

A significant catalyst for Canopy Growth to stage a major comeback in 2020 is the improving demand trends in the domestic market. Canada’s Cannabis 2.0 is a potential $2.7 billion industry. Consumers can choose from a variety of product mixes in the legal channel, including the popular edibles.

Expect more retail stores to open too. Canopy Growth is opening ten of its Tokyo Smoke dispensaries in the province of Ontario to widen its retail footprint. Another segment in the derivatives where the company would focus on and lead is cannabis-infused beverages.

Right timing

Canopy Growth is hoping the U.S. federal legalization of cannabis would happen this year. The launching of Fire & Free, a line of hemp-derived CBD products, is part of its pre-legalization expansion. If both components in the U.S. progress well, Canopy Growth’s sales should rise significantly.

Right direction

While Canopy Growth is one of the stocks to watch in 2020, don’t expect instant financial miracles. The catalysts for growth are present, beginning with a new man at the helm. Product margins should improve as cash burn declines. You can decide to buy the stock once the red flags go down.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »